CASI Pharmaceuticals Inc (NASDAQ:CASI)
| 3.19 Delayed Data As of Dec 09 |  -0.02 / -0.62%Today’s Change | 2.83 Today|||52-Week Range 4.58 | -20.65% Year-to-Date |
Latest CASI News | Press Releases
No recent news for CASI Pharmaceuticals Inc.
Today’s Trading
| Previous close | 3.21 |
| Today’s open | 3.21 |
| Day’s range | 3.18 - 3.27 |
| Volume | 87,883 |
| Average volume (3 months) | 161,470 |
| Market cap | $306.4M |
Data as of 4:00pm ET, 12/09/2019
Growth & Valuation
| Earnings growth (last year) | -80.06% |
| Earnings growth (this year) | -31.25% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PBYIPuma Biotechnology I... | -0.20 | -2.47% |
| MTNBMatinas BioPharma Ho... | -0.09 | -4.69% |
| EIGREiger BioPharmaceuti... | -0.03 | -0.23% |
| GRTSGritstone Oncology I... | +0.12 | +1.32% |
Data as of 8:00pm ET, 12/09/2019
Financials
| Next reporting date | March 20, 2020 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$27.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
